Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide. NNMT is strongly expressed in tumor cells and an increase in NNMT activity may reduce cellular nicotinamide level and thereby promote cell survival in the cells. However, there has been no report of a relationship between NNMT activity and nicotinamide level in tumor cells. We report herein that human glioma cells produce relatively large amounts of NNMT and that when these cells are cultured in the presence of interferon-␥ (IFN-␥ ) their 1-methylnicotinamide levels increase. To clarify the mechanisms by which IFN-␥ increases 1-methylnicotinamide levels in these cells, we measured NNMT activity and the levels of NNMT expression, nicotinamide and nicotinamide adenine dinucleotide (NAD ϩ ) in the presence and absence of IFN-␥ . We also examined whether addition of exogenous 1-methylnicotinamide directly affects cell viability and/or the cellular levels of 1-methylnicotinamide, nicotinamide and NAD ϩ . While addition of 1-methylnicotinamide increased the total amount of cellular 1-methylnicotinamide present, it did not affect nicotinamide or NAD ϩ levels, or cell viability. Conversely, IFN-␥ significantly increased NNMT activity and the nicotinamide cellular concentration, while leaving NNMT expression and the NAD ϩ cellular concentration unchanged. Therefore, the increase in the 1-methylnicotinamide level found when IFN-␥ is present in culture may be a consequence of increases in both the nicotinamide concentration and NNMT activity, whereas, 1-methylnicotinamide did not influence nicotinamide levels, NAD ϩ levels, or cell viability per se. These results suggest that an increase in NNMT activity does not always reduce cellular nicotinamide concentration in tumor cells.
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Methylation is an important reaction that often occurs during the biotransformation of drugs and xenobiotic compounds ( 1 ) . In healthy tissues, nicotinamide N-methyltransferase (NNMT) activity is found mainly in the liver where the enzyme catalyzes the N-methylation of nicotinamide to form 1-methylnicotinamide ( 2 ). However, NNMT expression is elevated in papillary thyroid ( 3 ), colorectal ( 4 ), bladder ( 5 ) , and renal ( 6 ) cancers and therefore may be a useful tumor marker.
Nicotinamide is a precursor of nicotinamide adenine dinucleotide (NAD ϩ ) and is also an inhibitor of the NAD ϩ -dependent deacetylase, silent information regulator 2 (sir2), which inhibits apoptosis and thereby positively regulates cell survival (7) (8) (9) . Thus fluctuations in nicotinamide and NAD ϩ levels probably modulate cell survival and apoptosis ( 8 ) . Increased NNMT activity in tumor cells may reduce nicotinamide levels and thus may promote cell survival. However, for tumor cells, it has not been established whether an increase in NNMT activity elevates 1-methylnicotinamide level and decreases nicotinamide level. During the investigation of 1-methylnicotinamide level in human glioma cells, we found that interferon-␥ (IFN-␥ ) increases the 1-methylnicotinamide concentration in the culture medium of the cells. We therefore examined the mechanisms by which IFN-␥ increases 1-methylnicotinamide levels in these cells.
We report herein that relatively large amounts of NNMT are produced in the glioma cells and that IFN-␥ increases NNMT activity and an increase in NNMT activity elevates nicotinamide concentration in these cells. We also examined the direct effect of 1-methylnicotinamide (by adding exogenous 1-methylnicotinamide to cell cultures) on cell viability and on the 1-methylnicotinamide, nicotinamide, and NAD ϩ levels.
MATERIALS AND METHODS
Materials . 1-Methylnicotinamide, S -adenosylmethionine, and minimum essential medium (MEM) were purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA).
[Carbonyl-MEM supplemented with 5% fetal bovine serum (FBS), 100 units/mL penicillin, and 50 g/mL streptomycin in a humidified atmosphere of 5% CO 2 and 95% air at 37˚C.
Reverse transcription-polymerase chain reaction ( RT-PCR ) of NNMT and glyceraldehyde-3-phosphate dehydrogenase ( GAPDH ) mRNAs. From total RNAs extracted from cells, random-primed single stranded cDNAs were synthesized from 1 g of total RNAs, using M-MLV reverse transcriptase (TOYOBO). cDNA mixtures were subjected to PCR using specific primers and rTth (TO-YOBO) under the following conditions: NNMT, once at 93˚C for 2 min and 28 cycles at 93˚C for 0.5 min, 58˚C for 0.5 min, 72˚C for 2 min; GAPDH, once at 93˚C for 2 min and 20 cycles at 93˚C for 0.5 min, 54˚C for 0.5 min, 72˚C for 2 min. The sequences of these primers were 5 ′ -TCAGGCTTCACCTCCAAGGACACC-3 ′ (forward) and 5 ′ -CTGGTCTGAGTAGTCAGTGACGACG-3 ′ (reverse) for NNMT and 5 ′ -ACCACAGTCCATGCCAT-CAC-3 ′ (forward) and 5 ′ -TCCACCACCCTGTTGCTGTA-3 ′ (reverse) for GAPDH. The PCR products were separated in a 1% agarose gel and visualized with ethidium bromide.
NNMT activity. . Protein concentrations were determined using the method of Bradford ( 11 ) with bovine serum albumin as a standard.
Cell viability . Cells were seeded at a density of 1 ϫ 10 3 cells/well in 96-well flat-bottomed plates and allowed to attach to the plates overnight. Subsequently, the media were removed and replaced with 5% FBS MEM containing different concentrations of 1-methylnicotinamide. The cells were then incubated at 37˚C for 72 h. Cell viability was determined using the WST-1 assay as described previously ( 12 ) .
Quantification of 1-methylnicotinamide , nicotinamide , and NAD ϩ . 1-Methylnicotinamide, nicotinamide, and NAD ϩ levels were determined using liquid chromatography/tandem mass spectrometry (LC/MS/MS) as described previously ( 13 ) .
Statistical analysis . Statistical analyses were performed using Student's t test with a significance of p Ͻ 0.01.
RESULTS AND DISCUSSION
Since IFN-␥ is known to induce apoptosis in tumor cells ( 14 ) and tumor cells express NNMT, we investigated the effect of IFN-␥ on the concentration of 1-methylnicotinamide in the LN229 human glioma cell. Cells were cultured in the absence or in the presence of 100 units/mL IFN-␥ . After 0, 24, or 48 h of culture, 1-methylnicotinamide levels in both cells and culture media were measured. IFN-␥ treatment increased 1-methylnicotinamide levels both extra-and intracellularly ( Fig. 1A and B) . We also examined the effect of IFN-␥ concentration up to 1,000 units/mL and found that a maximum increase in 1-methylnicotinamide level is observed at 100 units/mL IFN-␥ . Under that condition, IFN-␥ did not affect the cell viability (data not shown).
We next examined whether the increases in the IFN-␥ -induced 1-methylnicotinamide levels result from an increase in NNMT activity. To test this possibility we cultured cells in the absence and in the presence of IFN-␥ and then assayed for NNMT activity. IFN-␥ caused a significant increase in NNMT activity (Fig. 2) . Therefore, the larger amounts of 1-methylnicotinamide found when the cells are IFN-␥ treated may be caused by an increase in NNMT activity.
To determine whether the increase in IFN-␥-induced NNMT activity results from an increased NNMT mRNA transcription, total cellular RNAs were first extracted from the control and IFN-␥-treated cells and then the NNMT mRNA levels were determined using RT-PCR. We found that NNMT mRNA is highly expressed in the glioma cells. However, there was no significant difference in the NNMT message between the control and IFN-␥-treated cells as measured by RT-PCR (Fig. 3) . Therefore, the IFN-␥-induced increase in the 1-methylnicotinamide level does not result from an increase in NNMT mRNA.
To determine if the greater cellular concentrations of 1-methylnicotinamide induced by IFN-␥ are accompanied by a decrease in nicotinamide concentration, we measured nicotinamide and NAD ϩ levels in cells that had been cultured in the absence and presence of IFN-␥ (Fig. 4) . Unexpectedly, cells isolated from cultures containing IFN-␥ had significantly more nicotinamide, but not more NAD ϩ (Fig. 4) . IFN-␥ treatment may stimulate NAD ϩ degradation, thereby increasing the nicotinamide level. Alternatively, it may augment nicotinamide incorporation from culture medium. These results suggest that IFN-␥ may mediate the increase in 1-methylnicotinamide level by increasing the nicotinamide level.
Since IFN-␥ increases cellular 1-methylnicotinamide and nicotinamide levels, 1-methylnicotinamide may be converted to nicotinamide and an increase in nicotinamide level might affect cell viability and NAD ϩ levels. To examine this possibility, 1-methylnicotinamide was directly added to the culture media. Although addition of exogenous 1-methylnicotinamide increased the cellular 1-methylnicotinamide level, it did not change the nicotinamide or NAD ϩ levels, or cell viability (Table 1 ). These results suggest that an increase in nicotinamide level with IFN-␥ is not due to the conversion of 1-methylnicotinamide to nicotinamide.
We found that human glioma cells synthesize relatively large amounts of NNMT and that when they are cultured in the presence of IFN-␥ even more 1-methylnicotinamide is produced. Apparently, IFN-␥ increases NNMT activity and the cellular nicotinamide level, but does not increase NNMT synthesis or the cellular NAD ϩ level. Moreover, while addition of exogenous 1-methylnicotinamide increases the cellular 1-methylnicotinamide level, it does not influence nicotinamide or NAD ϩ levels, or cell viability. Therefore, an increase in the IFN-␥-mediated cellular 1-methylnicotinamide concentration may be a consequence of the increases in the nicotinamide concentration and in NNMT activity. The reason for increase in NNMT activity from IFN-␥ remains unclear. Recent proteomic analysis revealed that NNMT is also expressed in gastric cancer but not normal tissues (15) , and that NNMT is phosphorylated by casein kinase 2. Moreover, it was reported that IFN-␥ stimulates the expression of the inducible cAMP early repressor in macrophages by activating casein kinase 2 (16) . These results suggest the possibility that IFN-␥ increases casein kinase activity, which in turn phosphorylates NNMT, thereby augmenting NNMT activity.
It seems that an increase in 1-methylnicotinamide per se does not affect the nicotinamide level, the NAD ϩ level, or cell viability. Nicotinamide, a precursor of NAD ϩ , inhibits the NAD ϩ -dependent deacetylase, sir2, which prevents apoptosis and positively regulates cell survival (7) (8) (9) . Thus, changes in nicotinamide and/or NAD ϩ levels may influence the biological consequences of sir2 regulation, i.e. cell survival or apoptosis. In the present study, we hypothesized that an increase in NNMT activity may reduce nicotinamide concentration, thereby enhancing cell survival. IFN-␥ increased NNMT activity but elevated nicotinamide concentration. Although IFN-␥ is known to induce apoptosis in tumor cells, it does not appear that IFN-␥ causes apoptosis through the changes in nicotinamide level by NNMT via sir2. An increase in NNMT activity may not always decrease nicotinamide level in tumor cells. cells) present in the absence of exogenous 1-methylnicotinamide are set to 1. Cell viability was determined using the WST-1 assay as described in "Materials and Methods."
